Insomnia Chronic: Clinical Trials

9 trials for Insomnia Chronic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 recruiting, 4 completed. 9 Phase 2, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 29Recruiting 5, Completed 4
Phase 13Completed 2, Recruiting 1

Follow Insomnia Chronic: new trials by email Literature Review of Insomnia Chronic trials Research Report on Insomnia Chronic

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Deep Sleep in Older Adults
SleepSpaceRx CBT-I-IoT-AI, SleepEZ CBTi, Sleep Hygiene IoT - Insomnia, Insomnia Chronic
Phase 2RecruitingProactive Life Inc1802026-09-302026-10-20
Efficacy and Safety of APSTZD in the Treatment of Insomnia Disorder
APSTZD 1, APSTZD 2, APSTZD 3 - Insomnia, Insomnia Chronic
Phase 2RecruitingApsen Farmaceutica S.A.2222026-08-052026-08-21
Mindfulness Meditation for Insomnia
Instructed bedtime app-guided mindfulness meditation, Uninstructed app-guided mindfulness meditation, Sleep hygiene education - Sleep Initiation and Maintenance Disorders, Insomnia
Phase 1 / Phase 2RecruitingBrigham and Women's Hospital302026-03-312026-06-23
Efficacy of Trazodone to Treat Insomnia in Older Adults (TRADITION Study)
Trazodone 25 mg - Insomnia Chronic, Older People
Phase 2RecruitingCentre hospitalier de l'Université de Montréal (CHUM)402025-11-102025-12-08
Chinese Medicine in Treating Insomnia
Modified Suan ZaoRen Tang-TianWang BuXin Dan, Placebo - Insomnia Chronic
Phase 2RecruitingChinese University of Hong Kong762025-09-252026-07-27
The Efficacy and Safty of FMT in Patients With CID
fecal microbiota, Placebo, synbiotics - Insomnia Chronic, Fecal Microbiota Transplantation
Phase 1 / Phase 2CompletedPeking University Sixth Hospital802023-10-082026-02-27
Cannabinoids as a Treatment for Insomnia in Major Depression
25:1 CBD/THC, 5:1 CBD/THC, Placebo - Insomnia, Depressive Disorder, Major
Phase 2CompletedSt. Joseph's Healthcare Hamilton142023-08-282026-01-22
Montmorency Cherry Supplementation, Sleep, and Inflammation
Montmorency cherry supplement, Control - Insomnia Chronic, Inflammation
Phase 1 / Phase 2CompletedMichigan State University342023-02-182025-09-08
Effectiveness of BBT-I and Zopiclone for Chronic Insomnia
Brief behavioral therapy, Zopiclone - Insomnia Chronic
Phase 2CompletedI.M. Sechenov First Moscow State Medical University422015-04-072019-09-16

Narrower conditions

Sleep Initiation and Maintenance Disorders (9)  ·  Cognitive Dysfunction (2)  ·  Depression (2)  ·  Sleep Wake Disorders (2)  ·  Anxiety Disorders (1)  ·  Depressive Disorder, Major (1)  ·  Inflammation (1)  ·  Marijuana Abuse (1)  ·  Psychological Well-Being (1)

Broader conditions

Dyssomnias (9)  ·  Mental Disorders (9)  ·  Nervous System Diseases (9)  ·  Sleep Disorders, Intrinsic (9)  ·  Sleep Wake Disorders (7)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Behavior (2)  ·  Behavioral Symptoms (2)  ·  Cognition Disorders (2)  ·  Neurocognitive Disorders (2)  ·  Neurologic Manifestations (2)  ·  Signs and Symptoms (2)  ·  Chemically-Induced Disorders (1)  ·  Depressive Disorder (1)  ·  Mood Disorders (1)

Interventions

Fecal Microbiota Transplantation (1)  ·  Hypnotics and Sedatives (1)  ·  Synbiotics (1)  ·  Trazodone (1)  ·  zopiclone (1)

Sponsors

Apsen Farmaceutica S.A. (1)  ·  Brigham and Women's Hospital (1)  ·  Centre hospitalier de l'Université de Montréal (CHUM) (1)  ·  Chinese University of Hong Kong (1)  ·  I.M. Sechenov First Moscow State Medical University (1)  ·  Michigan State University (1)  ·  Peking University Sixth Hospital (1)  ·  Proactive Life Inc (1)  ·  St. Joseph's Healthcare Hamilton (1)

Countries

United States (3)  ·  Canada (2)  ·  Brazil (1)  ·  China (1)  ·  Hong Kong (1)

Top investigators

Benicio N Frey, MD, MSc, PhD (1)  ·  Daniel Taylor, PhD (1)  ·  Nirushi Kuhathasan, PhD (1)  ·  Polina Pchelina, PG student (1)  ·  Zhixiu Lin (1)

Results publications

PMID 28777364, PMID 42026772

NIH funding

2025 (1), K23AT012475 (1), R43AG097205 (1)